Back to Search Start Over

BEVACIZUMAB (B) PLUS IMMUNOTHERAPY (IT) PLUS CHEMOTHERAPY (C) (BIC) IN METASTATIC RENAL CELL CANCER (MRCC): RESULTS AND EVALUATION OF CIRCULATING T-REGULATORY CELLS (TREG) AND OTHER CYTOKINES. A GOIRC STUDY

Details

Database :
OpenAIRE
Journal :
Web of Science, ResearcherID
Accession number :
edsair.dedup.wf.001..3e5b155471abdcc579f2c01ff06b839b